8/10 2 19-S + 12 7/10 3 VSV-27 -3 § 0/10 * Mice in different groups (10 mice/group) were injected with 2 x 106 p.f.u, of HSV-1 (KOS) in the hind footpad.
t Diluted (1:2) ascitic fluid containing monoclonal antibody 19-S (virus neutralization titre in presence of complement 1 : 800) was injected i.p. (1 ml/mouse) either 3 h before (-3 h) or 12 h after infection ( + 12 h). Control mice received the same amount of ascitic fluid containing monoclonal antibody VSV-27 directed against VSV~qj at 3 h before infection.
No further mortalities were observed up to 65 days post-infection. § Administration of antibody 12 h after infection gave identical results.
protection against HSV infection. Both monoclonal antibodies (provided by Dr M. Zweig) immunoprecipitated corresponding glycoproteins and could neutralize HSV-1 in the presence of complement (Showalter et al., 1981) .
A total of 30 male BALB/c mice were injected in hind footpads with HSV-1 (2 × 106 p.f.u./ mouse) and divided into three groups of 10 mice each. Mice in group 1 had received, 3 h before infection, intraperitoneal (i.p.) injections (1.0 ml/mouse) of 19-S. Mice in group 2 were injected with identical amounts of 19-S at 12 h post-infection. Group 3 animals serving as controls, received at 3 h before infection, i.p. injections of ascitic fluid containing anti-vesicular stomatitis virus (serotype New Jersey; VSVm) antibody designated VSV-27 . The results (Table 1) showed that 19-S antibody effectively protected mice from HSV-induced death, irrespective of whether it was injected at 3 h before or at 12 h after infection. All the control mice (group 3) had died by 2 weeks. Similar results (not recorded) were obtained with gD-specific monoclonal antibody, 1-S as well as with several other independently isolated monoclonal antibodies directed against gC or gD. These observations are in accord with the work of others utilizing anti-HSV monoclonal antibodies or conventional antisera (Dix et al., 1981; Rector et al., 1982; Balachandran et al., 1982) . Since these monoclonal antibodies possessed the capacity to neutralize HSV-1 in vitro, the most plausible explanation of the protection conferred by the antibodies when injected 3 h before infection would be the direct neutralization of injected virus per se. However, it is inconceivable that the above mechanism would account for the protective effect of the antibody when injected 12 h after infection at which time the input virus had already infected the host tissues. In this situation, the proposed alternative mechanism(s) such as antibody-dependent cell-mediated cytotoxicity (Shore et al., 1974; Norrild et al., 1980) or antibody-dependent complement-mediated lysis of infected cells (Norrild et al., 1979) may have been responsible for the protective effect; unequivocal in vitro evidence in support of such mechanism(s) is, however, lacking.
The question of whether mice protected against HSV infection by passively injected monoclonal antibodies generate anti-HSV CTL was examined next. Groups of mice were treated with monoclonal antibodies 19-S, 1-S or VSV-27 and infected with HSV-1 as in the above experiment and their draining lymph nodes removed at the indicated time intervals to assess CTL activities. The results of a typical experiment (Table 2) showed that lymph node cells from mice receiving monoclonal antibodies at 12 h after infection had substantial lytic activity for HSV-infected, H-2 compatible P815 (H-2 a) cells when tested at day 7 post-infection; lymph node cells obtained at day 21 failed to exert significant lysis. The HSV-specific lytic activity of lymph node cell populations was eliminated on pretreatment with anti-Thy 1.2 antiserum in the presence of complement (data not shown), indicating the T-cell nature of the effectors. The specificity controls showed that these effectors were HSV-specific and H-2-restricted, since at equivalent effector/target cell ratios, significant amounts of S lCr were not released from HSV- :~ Draining lymph nodes of infected mice were excised and non-adherent cell suspensions, usually a pool of two mice, used as the effectors in cytolysis assays carried out as described previously (Sethi & Wolff, 1980) . Briefly, target cells [L-929 (H-2k); P815 (H-2d)] were infected with HSV-1 at a m.o.i, of 5 or with VSVNj (m.o.i. 20). After virus adsorption (37 °C for 1 h), cultures were washed and 106 cells incubated with 1 mCi Na251CrO4; mockinfected (including natural killer cell-sensitive YAC-1) cells were incubated with 51Cr as usual. After 2 h (HSVinfected) or 8 h (VSVsj-infected), cells were washed and suspended in growth medium (GM) consisting of RPMI 1640 (Flow Laboratories), 10~o heat-inactivated foetal calf serum, 20 mM-HEPES, 20 mM-glutamine, 5 × 10 -s M-2-mercaptoethanol and antibiotics. Aliquots (100 ixl; 104 cells) of test targets were mixed in round-bottomed plastic tubes with 100 ~tl of appropriate effectors to give an effector (E) to target (T) cell ratio of 30 : 1. After centrifugation (50g, 10 min) the tubes were incubated for 3 h at 37 °C. The tubes were re-centrifuged (400g, 10 min) in the cold and from each tube, 100 p~l of supernatant was counted in a gamma counter. The results are expressed as percentage specific 51Cr release according to the formula: 100 x (E -S)/M -S, where E = release in test, S = spontaneous release in presence of normal lymph node cells, and M = maximum release (ct/min) in 1 ~ Triton X-100. The tabulated values are means of quadruplicate assays in a typical experiment with standard errors < 2~ and are omitted. Spontaneous 51Cr release (3 h) values in the presence of normal lymph node cells ranged from 8 to 16~ for uninfected and 14 to 22 ~o for infected targets. The experiment was performed three times with concordant results and higher E :T ratios (50:1 or 75:1) showed an identical trend. § Significant specific lysis of slCr-labelled YAC-1 targets was not observed. When effectors were generated in C3H (H-2 k) mice, they showed specific lysis for HSV-l-infected L-929 (H-2 k) but not P815 (H-2 a) cells.
II ~r, Not tested.
infected, H-2-incompatible L-929 (H-2 k) cells or from VSVNj-infected or uninfected syngeneic P815 targets. Under identical test conditions, lymph node cells from HSV-infected mice which had received monoclonal antibodies at 3 h before infection or those derived from controls (given VSV-27 monoclonal antibodies) showed no appreciable lytic activity specific for HSV-infected P815 cells. Thus, passive administration of 19-S or 1-S at 12 h after infection but not at 3 h before infection induced a significant primary anti-HSV CTL response in the recipients.
In separate experiments, when lymph node cells from protected mice which had received monoclonal antibodies at 12 h were collected at day 21 after infection and restimulated in vitro, highly potent HSV-specific and H-2-restricted CTL were generated in such cultures (40.6~o specific SlCr release from HSV-infected P815 cells compared to 4.6~o of HSV-infected L-929 and 3.0 ~ of uninfected P815 targets). Secondary restimulation of lymph node cells from HSVinfected mice that had received no pretreatment also generated a detectable CTL response (mean specific 51Cr release from HSV-infected appropriate targets ranged from 36.5 to 40-0~ compared to control values of less than 5 ~). Strikingly, secondary in vitro restimulation did not generate a detectable CTL response when the responders were lymph node cells from virusinfected mice which had received monoclonal antibodies at 3 h before infection (mean specific S~Cr release being 5 to 8~o, which was equivalent to the control values). The inability of mice to elaborate CTL-precursors (CTL-P) when the monoclonal antibodies were given shortly before infection (3 h) is reminiscent of similar findings with influenza virus (Greenspan & Doherty, 1981) . However, an apparent anomaly in the present situation is that unlike the observations with influenza virus (Greenspan & Doherty, 1981) , late administration of monoclonal antibodies (i.e. 12 h after infection) could induce a potent CTL response. The precise mechanism(s) by which monoclonal antibodies effect the generation of CTL responses Short communication remain obscure. The inability to detect HSV-specific CTL-P in mice receiving monoclonal antibodies shortly before infection may be due to low levels of (or inadequately primed) CTL-P generated by antibody-neutralized virus preparations as reported for influenza virus (Greenspan & Doherty, 1981) . Presumably, inadequate helper cell activity, which is a prerequisite for the development of antigen-specific CTL-P (Wagner & R611inghoff, 1978) is elicited in this situation. Interestingly, anti-HSV titres were significantly elevated in the sera of these mice (data not shown), which suggests that anti-HSV CTL and humoral responses may be under the control of different regulatory mechanism(s). It is pertinent that mice exposed to heatinactivated HSV fail to generate CTL but develop elevated serum antibody titres (Naylor et al., 1982) .
